Stimcell Energetics (STME) Net Cash Flow Growth (3y) (2016 - 2026)
Stimcell Energetics (STME) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -48.90% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -50.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -50.02% |
| Nov 30, 2025 | 65.76% |
| Aug 31, 2025 | 17.79% |
| May 31, 2025 | 47.09% |
| Feb 28, 2025 | -58.57% |
| Nov 30, 2024 | 36.04% |
| Aug 31, 2024 | -36.39% |
| May 31, 2024 | -82.01% |
| Feb 29, 2024 | 224.22% |
| Nov 30, 2023 | 28.86% |
| Aug 31, 2023 | -36.33% |
| May 31, 2023 | 49.50% |
| Feb 28, 2023 | 59.43% |
| Nov 30, 2022 | 28.32% |
| Aug 31, 2022 | -27.03% |
| May 31, 2022 | 54.49% |
| Feb 28, 2022 | -27.29% |
| Nov 30, 2021 | -91.29% |
| Aug 31, 2021 | 100.23% |
| May 31, 2021 | 26.67% |